We use necessary cookies to make our site work. We'd also like to set optional cookies to help us measure web traffic and report on campaigns.
We won't set optional cookies unless you enable them.
Cookie settings
Experiences of and outcomes for Blackpool adults enrolled in the ADDER programme who are treated with buprenorphine prolonged-release injection (Buvidal) opioid substitution therapy 01/01/2022 → 31/01/2025 Research
Top
